questions to ask before starting semaglutide My weight loss program is next week! Here are some commonly asked about (Olympic or Wegovy). Highly recommend you watch if you are at all considering this medication! Semaglutide 3 mg tablet for

Following nucleation (and a subsequent desorption step), nucleated droplets grow rapidly, ultimately resulting

Discover whether your pen is still safe to use, how storage temperature affects effectiveness, and when to contact your GP or pharmacist for guidance on this diabetes medication.

After years of battling constant Why GLP-1 Medications Arent the Easy Path: Navigating Emotional Shifts and Finding Joy Beyond Food Read More

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with CKD and T2DM Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, GLP-1/GIP and other metabolic hormones for the treatment of CKD At the moment the most complete data is available for semaglutide from SUSTAIN-6 and FLOW trial which is the only trial with primary renal outcome in T2DM patients out of all GLP-1 RA Very good data for renal outcomes as secondary ones available for GLP-1 RAs dulaglutide and liraglutide and GLP-1/GIP RA tirzepatide, Very interesting and positive data from mechanistic REMODEL trial with semaglutide in T2DM patients presented but not yet published (reduced perirenal fat, rernal fibrosis and much more) Based on following excellent papers: #glp1 #gip #semaglutide #tirzepatide #liraglutide #dulaglutide #kidney #ckd #chronickidneydisease #cardiovascularcomplications

Month-by-month timeline, dose results, body composition, and realistic expectations.